Alzamend Neuro Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Alzamend Neuro Stock Summary

Alzamend Neuro competes with Solid Biosciences, Kezar Life, Senti Biosciences, X4 Pharmaceuticals, and Inozyme Pharma. Alzamend Neuro, Inc., an early clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. Alzamend Neuro, Inc. was incorporated in 2016 and is headquartered in Atlanta, Georgia. Alzamend Neuro operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 4 people.

Alzamend Neuro Key Financial Ratios

Alzamend Neuro Key Balance Sheet Accounts

Alzamend Neuro Key Income Statement Accounts

Alzamend Neuro Key Cash Accounts

Alzamend Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Alzamend Neuro's current stock value. Our valuation model uses many indicators to compare Alzamend Neuro value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Alzamend Neuro competition to find correlations between indicators driving Alzamend Neuro's intrinsic value. More Info.Alzamend Neuro is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . At this time, Alzamend Neuro's Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Alzamend Neuro's earnings, one of the primary drivers of an investment's value.

Alzamend Neuro Systematic Risk

Today, most investors in Alzamend Neuro Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Alzamend Neuro's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Alzamend Neuro growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Alzamend Neuro help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Alzamend Neuro. We use our internally-developed statistical techniques to arrive at the intrinsic value of Alzamend Neuro based on widely used predictive technical indicators. In general, we focus on analyzing Alzamend Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Alzamend Neuro's daily price indicators and compare them against related drivers.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alzamend Neuro. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. To learn how to invest in Alzamend Stock, please use our How to Invest in Alzamend Neuro guide.You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alzamend Neuro. If investors know Alzamend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alzamend Neuro listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Alzamend Neuro is measured differently than its book value, which is the value of Alzamend that is recorded on the company's balance sheet. Investors also form their own opinion of Alzamend Neuro's value that differs from its market value or its book value, called intrinsic value, which is Alzamend Neuro's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alzamend Neuro's market value can be influenced by many factors that don't directly affect Alzamend Neuro's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Alzamend Neuro's value and its price as these two are different measures arrived at by different means. Investors typically determine if Alzamend Neuro is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alzamend Neuro's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.